Angioimmunoblastic T‐cell lymphoma

10.1182/blood.V82.1.241.bloodjournal821241

10.1023/A:1008275208592

10.1136/jcp.42.6.668

10.1182/blood.V80.7.1804.1804

10.3109/10428199509059657

10.1002/1521-1878(200103)23:3<251::AID-BIES1035>3.0.CO;2-O

Antczak C.M., 2001, Transmembrane proteases as disease markers and targets for therapy, Journal of Biological Regulation and Homeostasis Agents, 15, 130

10.1182/blood.V99.2.627

Attygalle A.D., 2002, CD10 expression in extranodal dissemination of angioimmunoblastic T‐cell lymphoma, Modern Pathology, 15, 964

10.1007/BF00255768

10.1097/00022744-200106000-00003

10.1084/jem.194.7.927

10.1136/jcp.32.4.356

10.1034/j.1600-0560.2001.028008432.x

10.1002/(SICI)1097-0142(19970815)80:4<788::AID-CNCR18>3.0.CO;2-P

10.1097/00022744-200012000-00001

10.1159/000206997

Cosimi M.F., 1990, Rearrangements on chromosomes 7 and 14 with breakpoints at 7q35 and 14q11 in angioimmunoblastic lymphadenopathy and IBL‐like T‐cell lymphoma, Pathologica, 82, 391

Cutrona G., 1999, Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo, Blood, 94, 3067, 10.1182/blood.V94.9.3067

10.1097/00000478-200006000-00010

10.1053/hupa.2002.32215

Feller A.C., 1988, Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy, American Journal of Pathology, 133, 549

10.1111/j.1600-0609.1987.tb00176.x

10.1182/blood.V85.10.2862.bloodjournal85102862

10.1002/(SICI)1096-9896(199709)183:1<44::AID-PATH1103>3.0.CO;2-I

10.1016/S0140-6736(74)90553-4

Frizzera G., 1989, Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions, Leukemia, 3, 1

10.3109/10428190109099333

Gerlando Q., 2000, Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia‐type T‐cell lymphoma by combined methotrexate and prednisone, Haematologica, 85, 880

10.1111/j.1365-2141.1985.tb02819.x

10.1016/0145-2126(87)90024-5

10.1136/ard.60.3.293

10.1111/j.1600-0609.1991.tb00515.x

10.3109/10428199909058489

10.1016/S0190-9622(08)81242-X

Jaffe E.S., 2001, World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue

10.1097/00000478-199808000-00005

10.1182/blood.V93.10.3487.410k39_3487_3493

10.1182/blood.V96.2.685

Kaneko Y., 1982, Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy, Blood, 60, 877, 10.1182/blood.V60.4.877.877

Kaneko Y., 1988, Characteristic karyotypic pattern in T‐cell lymphoproliferative disorders with reactive ‘angioimmunoblastic lymphadenopathy with dysproteinemia‐type’ features, Blood, 72, 413, 10.1182/blood.V72.2.413.413

10.1038/labinvest.3780382

10.1111/j.1365-2559.1993.tb00093.x

Knecht H., 1995, A deletion mutant of the LMP1 oncogene of Epstein–Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma, Leukemia, 9, 458

10.1111/j.1439-0507.1991.tb00665.x

Lennert K., 1979, [Nature, prognosis and nomenclature of angioimmunoblastic lymphadenopathy (lymphogranulomatosis X or T‐zone lymphoma)], Deutsche Medizin Wochenschrift, 104, 1246

10.1111/j.1365-2559.1993.tb00491.x

10.1097/00000478-200103000-00015

10.1172/JCI112860

Lorenzen J., 1994, Angioimmunoblastic lymphadenopathy type of T‐cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin‐embedded tissues, Virchows' Archives, 424, 593, 10.1007/BF00195772

10.1056/NEJM197501022920101

Luppi M., 1996, The new lymphotropic herpesviruses (HHV‐6, HHV‐7, HHV‐8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview, Haematologica, 81, 265

10.1016/0145-2126(93)90049-Q

10.1182/blood.V87.9.3903.bloodjournal8793903

10.1016/S0002-9440(10)65623-4

10.1001/archderm.136.7.881

10.1016/0002-9343(79)90407-8

10.1111/j.1365-2141.1990.tb04363.x

10.1046/j.1365-2133.2001.04150.x

10.1002/1097-0142(19920515)69:10<2567::AID-CNCR2820691029>3.0.CO;2-M

10.1007/978-3-642-81246-0_27

10.1002/cncr.2820690531

10.1111/j.1365-2559.1994.tb01376.x

10.3109/10428190009059273

Ong S.T., 1996, Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine, Blood, 88, 2354, 10.1182/blood.V88.6.2354.bloodjournal8862354

10.1038/nm0198-050

10.3109/10428199909058412

10.1053/hupa.2001.21569

10.1007/BF02032474

10.1002/1097-0142(19871115)60:10<2412::AID-CNCR2820601010>3.0.CO;2-F

10.1111/j.1365-2141.1990.tb07786.x

Raymond I., 1997, CNA.42, a new monoclonal antibody directed against a fixative‐resistant antigen of follicular dendritic reticulum cells, American Journal of Pathology, 151, 1577

10.1097/00000478-199806000-00001

10.1016/S0046-8177(99)90115-6

10.1007/s002770050182

10.1093/annonc/mdf033

10.1007/s002770050244

Sasaki T.Y., 2000, Angioimmunoblastic T‐cell lymphoma (AIL‐TCL) following macrolide administration, Hawaii Medical Journal, 59, 56

10.1016/0165-4608(90)90233-Z

Schlegelberger B., 1990, Angioimmunoblastic lymphadenopathy with trisomy 3: the cells of the malignant clone are T cells, Hematological Pathology, 4, 179

10.1182/blood.V84.8.2640.2640

10.1200/JCO.1996.14.2.593

10.1111/j.1365-2141.1991.tb04544.x

Seehafer J.R., 1980, Cutaneous manifestations of angioimmunoblastic lymphadenopathy, Archives of Dermatology, 116, 41, 10.1001/archderm.1980.01640250043013

10.1073/pnas.88.23.10662

Siegert W., 1991, Recombinant human interferon‐alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients, Leukemia, 5, 892

10.7326/0003-4819-117-5-364

10.1093/oxfordjournals.annonc.a059281

10.1016/S0002-9440(10)64770-0

10.1016/S0140-6736(88)90367-4

10.1080/10428190210190

10.1111/j.1346-8138.2001.tb00083.x

Sumitomo M., 2000, Neutral endopeptidase promotes phorbol ester‐induced apoptosis in prostate cancer cells by inhibiting neuropeptide‐induced protein kinase C delta degradation, Cancer Research, 60, 6590

Sumitomo M., 2001, Neutral endopeptidase inhibits neuropeptide‐mediated transactivation of the insulin‐like growth factor receptor–Akt cell survival pathway, Cancer Research, 61, 3294

10.3109/10428199909145744

10.1016/S0344-0338(11)80112-3

Tobinai K., 1988, Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy‐like T‐cell lymphoma, Blood, 72, 1000, 10.1182/blood.V72.3.1000.bloodjournal7231000

10.1159/000046545

10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K

Weiss L.M., 1986, Clonal T‐cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy‐like lymphoma, American Journal of Pathology, 122, 392

10.1182/blood.V79.7.1789.1789

10.1016/S0002-9440(10)64141-7

Yuan C.M., 2002, Angioimmunoblastic T‐cell lymphoma: a neoplasm of intrafollicular CD10+, BCL‐6+, CD4+ memory T‐cells?, Modern Pathology, 15, 1125

10.1309/6UTX-GVC0-12ND-JJEU